Spearman, C. Wendy
Andersson, Monique I.
Bright, Bisi
Davwar, Pantong M.
Desalegn, Hailemichael
Guingane, Alice Nanelin
Johannessen, Asgeir
Kabagambe, Kenneth
Lemoine, Maud
Matthews, Philippa C.
Ndow, Gibril
Riches, Nicholas
Shimakawa, Yusuke
SombiƩ, Roger
Stockdale, Alexander J.
Taljaard, Jantjie J.
Vinikoor, Michael J.
Wandeler, Gilles
Okeke, Edith
Sonderup, Mark
,
Funding for this research was provided by:
GILEAD Sciences for the Women Hepatitis Champions Training in Mauritius, Nigeria and Egypt
Received funding from GILEAD Sciences for NOPLHB
Received funding from MRC UKRI.
Wellcome Trust (110110/Z/15/Z)
The Francis Crick Institute
UCL NIHR Biomedical Research Centre
Received funding from GILEAD Sciences for research
Research funding from GILEAD Sciences and research materials from Abbott and Fujirebio Inc.
National Institute for Health and Care Research (UK) Senior Clinical Lectureship at the University of Liverpool
U.S. National Institutes of Health Grant (R01AI147727)
Supported by a Professorship grant from the Swiss National Science Foundation (PP00P3_211025)
Received unrestricted research grants from Gilead Sciences and Roche Diagnostics
Article History
Received: 27 July 2023
Accepted: 2 October 2023
First Online: 2 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: ML has received consultancy fees from Abbott and GILEAD Sciences.CWS has received Speaker Bureau Fees for educational purposes from GILEAD Sciences and Abbott.MWS has received Speaker Bureau Fees for educational purposes from GILEAD Sciences.GW has received fees for advisory boards and lectures from MSD, Gilead Sciences and ViiV; all these fees were paid to his institution.The remaining authors declare that they have no competing interests.